DrugPatentWatch Database Preview
VASOTEC Drug Profile
see a sample report or, see our see our flat-rate plans
Which patents cover Vasotec, and what generic alternatives are available?
The generic ingredient in VASOTEC is enalapril maleate. There are twenty-seven drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the enalapril maleate profile page.
Summary for VASOTEC
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Suppliers / Packagers: | 5 |
| Bulk Api Vendors: | 89 |
| Clinical Trials: | 6 |
| Patent Applications: | 2,171 |
| Formulation / Manufacturing: | see details |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for VASOTEC |
| DailyMed Link: | VASOTEC at DailyMed |
Pharmacology for VASOTEC
| Drug Class | Angiotensin Converting Enzyme Inhibitor |
| Mechanism of Action | Angiotensin-converting Enzyme Inhibitors |
| Physiological Effect | Decreased Blood Pressure |
Medical Subject Heading (MeSH) Categories for VASOTEC
Synonyms for VASOTEC
| ((S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)-L-alanyl-L-proline |
| (2S)-1-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]propanoyl]pyrrolidine-2-carboxylic aci |
| (2S)-1-[(2S)-2-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]propanoyl]pyrrolidine-2-carboxylic acid; maleic acid |
| (2S)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid |
| (2S)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]pyrrolidine-2-carboxylic acid |
| (S,S,S)-1-[2-(1-Ethoxycarbonyl-3-phenyl-propylamino)-propionyl]-pyrrolidine-2-carboxylic acid |
| (S,S,S)-Enalapril Maleate |
| (S)-(-)-1-[N-(1-Ethoxycarbonyl-3-phenylpropyl)-L-alanyl]-Lproline |
| (S)-1-((S)-2-(((S)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl)amino)propanoyl)pyrrolidine-2-carboxylic acid |
| (S)-1-((S)-2-((R)-1-ethoxy-1-oxo-4-phenylbutan-2-ylamino)propanoyl)pyrrolidine-2-carboxylic acid |
| (S)-1-((S)-2-((S)-1-ETHOXY-1-OXO-4-PHENYLBUTAN-2-YLAMINO)PROPANOYL)PYRROLIDINE-2-CARBOXYLIC ACID MALEATE |
| (S)-1-(N-(1-(Ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-L-proline |
| (S)-1-(N-(1-(Ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-L-proline maleate |
| (S)-1-(N-(1-(Ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-L-proline maleate (1:1) |
| (S)-1-[(R)-2-((R)-1-Ethoxycarbonyl-3-phenyl-propylamino)-propionyl]-pyrrolidine-2-carboxylic acid |
| (S)-1-[N-[1-(ETHOXYCARBONXYL)-3-PHENYLPROPYL]-L-AL |
| (S)-1-[N-[1-(ETHOXYCARBONXYL)-3-PHENYLPROPYL]-L-ALANYL]-L-PROLINE |
| (S)-1-[N-[1-(ETHOXYCARBONYL)-3-PHENYLPROPYL]-L-ALANYL]-L-PROLINE MALEATE |
| (S)-1-{(S)-2-[1-((S)-Ethoxycarbonyl)-3-phenyl-propylamino]-propionyl}-pyrrolidine-2-carboxylic acid |
| (S)-N-[1-(Ethoxycarbonyl)-3-phenylpropyl]-Ala-Pro maleate salt |
| (SSS)1-[2-(1-Ethoxycarbonyl-3-phenyl-propylamino)-propionyl]-pyrrolidine-2-carboxylic acid |
| (Z)-but-2-enedioic acid; (2S)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid |
| (Z)-but-2-enedioic acid;(2S)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid |
| 095E164 |
| 1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline 1'-ethyl ester |
| 1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline 1'-ethyl ester, maleate (1:1) |
| 1-[2-(1-Ethoxycarbonyl-3-phenyl-propylamino)-propionyl]-pyrrolidine-2-carboxylic acid |
| 1-[2-(1-Ethoxycarbonyl-3-phenyl-propylamino)-propionyl]-pyrrolidine-2-carboxylic acid (Enalapril) |
| 1-[2-(1-Ethoxycarbonyl-3-phenyl-propylamino)-propionyl]-pyrrolidine-2-carboxylic acid(enalapril) |
| 1-[N-[(S)-1-Ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-L-proline Maleate |
| 172964-46-4 |
| 2-[2-(1-Carboxy-3-phenyl-propylamino)-propionyl]-1,2,3,4-tetrahydro-isoquinoline-3-carboxylic acid(enalapril) |
| 69PN84IO1A |
| 75847-73-3 |
| 75847-73-3 (Parent) |
| 76095-16-4 |
| 76095-16-4 (maleate) |
| 76420-75-2 |
| 77549-58-7 |
| 77549-59-8 |
| 847E733 |
| 9O25354EPJ |
| A-Rin |
| AB00053615_19 |
| AB00053615_20 |
| AB00053615-17 |
| AB00053615-18 |
| AB0013100 |
| AB03713 |
| AB2000386 |
| AC1NTUS2 |
| AC1NTUS5 |
| Acetensil |
| AK325516 |
| AK486954 |
| AKOS016340376 |
| AKOS025310615 |
| Alphrin |
| Amprace |
| AN-15422 |
| analapril |
| Analept |
| AOB5651 |
| API0002541 |
| Atens |
| Baripril |
| BDBM50017129 |
| Benalapril |
| Benalipril |
| BIDD:GT0751 |
| Biocronil |
| BPBio1_000340 |
| BQL |
| BSPBio_000308 |
| BSPBio_003035 |
| C-21264 |
| C06977 |
| C20H28N2O5 |
| C20H28N2O5.C4H4O4 |
| CAS-75847-73-3 |
| CAS-76095-16-4 |
| CC-27456 |
| CCG-39221 |
| CHEBI:4784 |
| CHEBI:4785 |
| CHEMBL1200659 |
| CHEMBL578 |
| Controlvas |
| Converten |
| Convertin |
| Coprilor |
| Coroldil |
| CPD001906771 |
| Crinoren |
| CS-2373 |
| CS-2918 |
| CTK8F9436 |
| D00621 |
| D00SEB |
| D07892 |
| Dabonal |
| DB00584 |
| Defluin |
| Denapril |
| Ditensor |
| DivK1c_000408 |
| DR002110 |
| DSSTox_CID_2982 |
| DSSTox_GSID_22982 |
| DSSTox_RID_76817 |
| DTXSID5022982 |
| Ecapril |
| Ednit |
| Ednyt |
| EINECS 278-375-7 |
| EINECS 278-460-9 |
| Elfonal |
| Enacard |
| Enalabene |
| Enaladex |
| Enaladil |
| enalapril |
| Enalapril (INN) |
| Enalapril (maleate) |
| Enalapril (TN) |
| Enalapril [INN:BAN] |
| ENALAPRIL 2-BUTENEDIOATE |
| enalapril hydrogen maleate |
| Enalapril maleate |
| Enalapril maleate (JP17/USP) |
| Enalapril maleate (Vasotec) |
| Enalapril maleate [USAN:JAN] |
| Enalapril maleate [USAN:USP:JAN] |
| Enalapril maleate salt |
| Enalapril Maleate Usp Xxi |
| Enalapril Richet |
| Enalapril, AldrichCPR |
| Enalaprila |
| Enalaprila [INN-Spanish] |
| Enalaprilmaleate |
| Enalaprilum |
| Enalaprilum [INN-Latin] |
| Enalasyn |
| Enaloc |
| Enalped |
| Enap |
| Enapren |
| Enapres |
| Enapril |
| Enaprin |
| Enarenal |
| Enaril |
| Envas |
| Epaned |
| Epaned Kit |
| Eupressin |
| Feliberal |
| GBXSMTUPTTWBMN-XIRDDKMYSA-N |
| Glioten |
| Glioten;Renitec;Vasotec |
| GTPL6322 |
| H531 |
| HE386417 |
| Herten |
| Hipoartel |
| Hipten |
| HMS1921B10 |
| HMS2090E08 |
| HMS2092L17 |
| HMS2095P10 |
| HMS2231D22 |
| HMS2232I24 |
| HMS501E10 |
| HSDB 6529 |
| HY-B0331 |
| HY-B0331A |
| Hytrol |
| I04-153 |
| IDI1_000408 |
| Innovace |
| Innovace Melt |
| Innovade |
| Inoprilat |
| Insup |
| Invoril |
| J10412 |
| K298 |
| KBio1_000408 |
| KBio2_001787 |
| KBio2_004355 |
| KBio2_006923 |
| KBio3_002535 |
| KBioGR_000355 |
| KBioSS_001787 |
| Kenopril |
| KM1738 |
| Konveril |
| KS-1137 |
| L-Proline, 1-(N-(1-(ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-, (S)- |
| L-Proline, 1-(N-(1-(ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-, (S)-, (Z)-2-butenedioate (1:1) |
| L-Proline, N-((1S)-1-(ethoxycarbonyl)-3-phenylpropyl)-L-alanyl- |
| L-Proline, N-((1S)-1-(ethoxycarbonyl)-3-phenylpropyl)-L-alanyl-, (2Z)-2-butenedioate (1:1) |
| L-Proline, N-[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]-L-alanyl- |
| Lapril |
| Lipraken |
| Lotrial |
| LS-118938 |
| LS-190651 |
| Mapryl |
| Mepril |
| MFCD00133304 |
| MFCD00865774 |
| Minipril |
| MK 421 |
| MK 421 maleate |
| MK-421 |
| MLS000028657 |
| MLS001077272 |
| MLS006010047 |
| MolPort-002-885-877 |
| MolPort-003-666-389 |
| N-((S)-1-Ethoxycarbonyl-3-phenylpropyl)-L-alanyl-L-proline maleate (1:1) |
| N-(1 (S)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl-L-proline maleate |
| N-(1(S)-Ethoxycarbonyl-3-phenylpropyl)-L-alanyl-L-proline |
| N-(1(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl-L-proline maleate |
| N-[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]-L-alanyl-L-proline |
| N-[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]-L-alanyl-L-proline (2Z)-but-2-enedioate |
| N-[(S)-1-ETHOXYCARBONYL-3-PHENYLPROPYL]-L-ALANYL]-L-PROLINE MALEATE(1: 1) |
| N-[1-(S)-ethoxycarbonyl-3-phenylpropyl]-L-alanyl-L-proline |
| N-[1(S)-Ethoxycarbonyl-3-phenylpropyl]-L-alanyl-L-proline maleic acid salt |
| N-{(1S)-1-[(ethyloxy)carbonyl]-3-phenylpropyl}-L-alanyl-L-proline |
| N-{N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl}-L-proline hydrogen maleate |
| Nalpha -[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl-L-proline |
| Naprilene |
| Naritec |
| NCGC00016932-01 |
| NCGC00021569-04 |
| NCGC00021569-05 |
| NCGC00021569-06 |
| NCGC00021569-09 |
| Neotensin |
| NINDS_000408 |
| Norpril |
| NSC-758143 |
| NSC758143 |
| Nuril |
| Opera_ID_1793 |
| OYFJQPXVCSSHAI-QFPUQLAESA-N |
| Palane |
| Pharmakon1600-01501214 |
| Pres |
| Presil |
| Pressotec |
| Prestwick_197 |
| Prestwick3_000314 |
| Pril |
| Prilenap |
| PRO106 |
| Pulsol |
| Reca |
| Regomed |
| Renavace |
| Renitec |
| Reniten |
| Renivace |
| Renivace (TN) |
| Repantril |
| Ristalen |
| s1941 |
| SAM002564252 |
| SBI-0051691.P002 |
| SC-17520 |
| SC-76440 |
| SCHEMBL18 |
| SCHEMBL9 |
| Sintec |
| SMR000058883 |
| SMR000653477 |
| SPBio_001349 |
| Spectrum_001307 |
| SPECTRUM1501214 |
| Spectrum2_001455 |
| Spectrum3_001478 |
| Spectrum4_000008 |
| Spectrum5_001107 |
| SR-01000000234 |
| SR-01000000234-4 |
| ST51052621 |
| Tenace |
| Tensazol |
| Tox21_110872 |
| Tox21_110872_1 |
| Unaril |
| UNII-69PN84IO1A |
| UNII-9O25354EPJ |
| Vapresan |
| Vasopril |
| Xanef |
| ZINC3791297 |
US Patents and Regulatory Information for VASOTEC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biovail Labs Intl | VASOTEC | enalaprilat | INJECTABLE;INJECTION | 019309-001 | Feb 9, 1988 | DISCN | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Valeant Pharms North | VASOTEC | enalapril maleate | TABLET;ORAL | 018998-002 | Dec 24, 1985 | AB | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
| Valeant Pharms North | VASOTEC | enalapril maleate | TABLET;ORAL | 018998-005 | Jul 26, 1988 | AB | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
| Valeant Pharms North | VASOTEC | enalapril maleate | TABLET;ORAL | 018998-001 | Dec 24, 1985 | AB | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
see a sample report or, see our see our flat-rate plans
Expired US Patents for VASOTEC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Valeant Pharms North | VASOTEC | enalapril maleate | TABLET;ORAL | 018998-002 | Dec 24, 1985 | ➤ Try a Free Trial | ➤ Try a Free Trial |
| Biovail Labs Intl | VASOTEC | enalaprilat | INJECTABLE;INJECTION | 019309-001 | Feb 9, 1988 | ➤ Try a Free Trial | ➤ Try a Free Trial |
| Valeant Pharms North | VASOTEC | enalapril maleate | TABLET;ORAL | 018998-003 | Dec 24, 1985 | ➤ Try a Free Trial | ➤ Try a Free Trial |
| Valeant Pharms North | VASOTEC | enalapril maleate | TABLET;ORAL | 018998-001 | Dec 24, 1985 | ➤ Try a Free Trial | ➤ Try a Free Trial |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
see a sample report or, see our see our flat-rate plans
